#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16552	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2150	765.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1540	1540	C	983	C	905	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16552	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2150	765.8	0	HET	.	.	.	A662G	.	662	662	A	1018	1018	A	983	A,G	692,186	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30436	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3554	854.0	0	.	n	.	0	T695C	SNP	695	695	T	996	996	C	963	C	889	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30436	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3554	854.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1638	1638	A	1032	A,G	944,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30436	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3554	854.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2272	2272	C	948	C,T	856,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30436	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3554	854.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2346	2346	A	964	A	883	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30436	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3554	854.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2898	2898	C	922	C	855	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	20	blaTEM	861	218	100.0	blaTEM.l6.c30.ctg.1	318	2.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	0	20	blaTEM	861	170	100.0	blaTEM.l6.c30.ctg.2	268	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	G5V	NONSYN	13	15	GGT	360	362	GTT	117;118;116	G;T;T	113;113;111	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	E12K	NONSYN	34	36	GAA	381	383	AAA	141;140;140	A;A;A	130;129;129	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	F31L	NONSYN	91	93	TTT	438	440	TTG	179;179;179	T;T;G	161;163;160	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	471	473	CAA	217;218;217	C;A;A	195;199;198	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	S75P	NONSYN	223	225	TCC	570	572	CCT	200;200;201	C;C;T	180;179;181	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	V87A	NONSYN	259	261	GTA	606	608	GCA	195;195;191	G;C;A	184;183;182	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	V130L	NONSYN	388	390	GTC	735	737	CTC	233;234;236	C;T;C	215;213;220	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	R135C	NONSYN	403	405	CGC	750	752	TGT	234;230;229	T;G;T	214;212;208	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	T137A	NONSYN	409	411	ACG	756	758	GCG	228;228;230	G;C;G	211;208;211	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	798	800	AAG	206;207;205	A;A,G;G	197;195,1;192	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	801	803	AAT	203;206;205	A;A;T	193;196;193	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	F218L	NONSYN	652	654	TTT	999	1001	TTG	142;140;136	T;T;G	134;134;129	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1029	1031	AGC	110;110;110	A;G;C	103;104;103	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1098	1100	CTG	84;85;85	C;T;G	80;77;81	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1104	1106	TCC	78;79;79	T;C;C	75;76;76	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1119	1121	GTG	87;88;90	G;T;G	81;77;83	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1696	folP	852	852	93.78	folP.l15.c4.ctg.1	1541	109.7	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1170	1172	GCG	136;133;130	G;C;G	126;122;121	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5794	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3444	167.7	1	SNP	p	S91F	0	.	.	271	273	TCC	567	569	TCC	198;198;198	T;C;C	178;179;180	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5794	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3444	167.7	1	SNP	p	D95N	0	.	.	283	285	GAC	579	581	GAC	196;198;196	G;A;C	171;175;175	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5794	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3444	167.7	1	SNP	p	D95G	0	.	.	283	285	GAC	579	581	GAC	196;198;196	G;A;C	171;175;175	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1748	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1415	123.2	1	SNP	p	G45D	1	.	.	133	135	GAC	511	513	GAC	213;213;212	G;A,G;C	201;197,1;200	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	940	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	881	106.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	5608	parC	2304	2304	99.74	parC.l15.c4.ctg.1	2912	192.0	1	SNP	p	D86N	0	.	.	256	258	GAC	590	592	GAC	248;250;250	G;A;C	229;230;230	parC.WHO_X_00208c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4622	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2577	178.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1549	1551	GGC	240;238;239	G;G;C	223;219;221	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1204	1206	GCA	250;246;246	G,A,T;C,T,G;A	227,1,1;222,1,1;228	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1207	1209	ATC	247;248;249	A;T;C	227;228;228	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1219	1221	GTG	245;243;241	G;T;G	219;219;217	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1219	1221	GTG	245;243;241	G;T;G	219;219;217	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1723	1725	ACC	212;212;213	A;C;C	187;191;192	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1777	1779	GCG	182;183;182	G;C;G	157;138;144	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1777	1779	GCG	182;183;182	G;C;G	157;138;144	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1900	1902	GGC	219;219;220	G,A;G;C	187,1;193;193	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1909	1911	GGC	214;212;210	G,C;G;C	187,1;186;188	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4464	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2227	199.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1927	1929	CTG	201;201;202	C,G;T;G	139,5;140;156	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6302	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3124	201.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2464	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1780	137.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	406	408	GGC	163;161;162	G;G;C	146;145;148	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2464	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1780	137.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	588	588	C	170	C	158	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	V75I	NONSYN	223	225	GTT	493	495	ATT	243;244;244	A;T;T	221;222;225	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	T89S	NONSYN	265	267	ACC	535	537	AGC	273;273;273	A;G;C	249;247;246	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	V98I	NONSYN	292	294	GTC	562	564	ATC	273;272;268	A,G;T;C	248,1;246;251	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	.	MULTIPLE	358	359	AA	627	628	CG	232;231	C;G	215;207	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	.	MULTIPLE	361	362	GA	630	632	CAG	234;235;233	C;A,G;G,C	215;215,1;214,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	634	636	AAA	238;238;235	A;A;A,C	221;220;220,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	661	663	TAT	258;257;263	T;A;T	237;238;239	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	N134E	NONSYN	400	402	AAT	670	672	GAG	262;265;268	G,T;AG,A;G	241,1;255,1;249	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	V135F	NONSYN	403	405	GTG	673	675	TTT	271;275;275	T;T,C;T	242;250,1;253	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	G140K	NONSYN	418	420	GGA	688	690	AAA	264;263;261	A;A;A	243;243;242	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	K143E	NONSYN	427	429	AAA	697	699	GAA	270;269;272	G;A;A	243;240;242	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	721	723	GCA	288;288;288	G;C,T;A	260;261,1;261	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	904	904	T	272	T	255	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	1	SNP	p	G120K	1	.	.	358	360	AAG	627	629	CGG	232;231;231	C;G;G	215;207;213	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	1	SNP	p	D121N	0	.	.	361	363	GAC	630	633	CGC	234;233;234	C;G,C;C	215;214,1;217	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3298	porB1b	1041	1041	96.37	porB1b.l15.c17.ctg.1	1447	224.3	1	SNP	p	A121D	1	.	.	361	363	GAC	630	633	CGC	234;233;234	C;G,C;C	215;214,1;217	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12090	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4778	252.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1274	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	963	131.6	1	SNP	p	V57M	1	.	.	169	171	ATG	474	476	ATG	268;266;266	A;T;G,T	251;247;246,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
